Osteogenesis imperfecta: Are fractures and growth hormone treatment linked? [1] (multiple letters)

Journal of Pediatrics

Volumn 132, Issue 3 I, 1998, Pages 559-560

  Kodama, H ^a   Kubota, K ^a   Abe, T ^a   Antoniazzi, F ^a   Zamboni, G ^a   Tato, L ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GROWTH HORMONE; PAMIDRONIC ACID; SOMATOMEDIN C;

BONE DENSITY; BONE MINERAL; CASE REPORT; CHILD; FEMALE; FRACTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LUMBAR SPINE; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL;

EID: 0031942741     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70044-7     Document Type: Letter

References (5)

1. F Antoniazzi F Bertoldo M Mottes M Valli S Sirpresi G Zamboni Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis J Pediatr 129 1996 432 439
2. JP Huaux W Lokietek Is APD a promising drug in the treatment of severe osteogenesis imperfecta? J Pediatr Orthop 8 1988 71 72
3. R Samuel K Katz SE Papapoulos Z Yosipovitch R Zaizov UA Liberman Aminohydroxy propylidene bisphophonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease Pediatrics 94 1994 385 389
4. NK Valk RJ Erdtsieck D Algra SWJ Lamberts HAP Pols Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass Clin Endocrinol 43 1995 317 324
5. K Fujita Z Kizaki F Inoue N Kodo N Furukawa A Kinugasa A case of osteogenesis imperfecta type IA who accompanied increased frequency of bone fractures by GH therapy S Suwa Proceedings of the 4th Meeting of the Research Society for the Growth Disturbance in Children 1990 Jeff Corporation Tokyo 173 179